Question explored with the scientific record
KPV peptide
KPV is a three-amino-acid fragment of a natural anti-inflammatory hormone. The evidence for it is thin, old, and mostly from mice.
The KPV peptide (lysine-proline-valine) is the C-terminal tail of alpha-melanocyte-stimulating hormone (alpha-MSH). A 2003 study in mice found that KPV reduced neutrophil migration into the peritoneal cavity by about 35-42% in two different inflammation models [1]. That effect worked through a pathway that did not involve the usual melanocortin receptors, which is unusual and means the mechanism is not well understood [1]. The same study tested KPV on isolated macrophages and found no direct effect on them at all, which means the anti-inflammatory action probably requires the whole living animal [1].
That is the only study in your evidence that directly tests KPV's biological effects. The rest of the retrieved evidence is about unrelated peptides: formyl peptides, C5a antibodies, and chemotaxis in cows and rabbits. None of it answers the question about KPV.
The 2017 study on KPV is about how to get it through the skin using iontophoresis and microneedles, not about whether it works [15]. It shows you can deliver it, but says nothing about what it does once it gets there.
| What was tested | Model | Effect | Source |
|---|---|---|---|
| KPV (3-9 nmol) | Mouse peritonitis (MSU crystals) | 35-42% reduction in neutrophil migration | [1] |
| KPV (3-9 nmol) | Mouse peritonitis (IL-1beta) | 32-35% reduction in neutrophil migration | [1] |
| KPV (3-88 uM) | Isolated mouse macrophages | No effect on cytokine release | [1] |
The evidence base is a single 2003 mouse study with small groups and no replication. No human trials, no safety data, no dose-ranging in people, no long-term studies. The mechanism is unclear because it bypasses the known receptors. The delivery study from 2017 is a formulation paper, not a therapeutic trial.
My call: KPV has a plausible anti-inflammatory signal in one mouse model from 23 years ago, but there is no human evidence at all. Confidence: low.
Sources used 2
-
Dissection of the Anti-Inflammatory Effect of the Core and C-Terminal (KPV) α-Melanocyte-Stimulating Hormone Peptides
The study shows that the C-terminal KPV fragment of alpha-MSH exerts anti-inflammatory effects in mouse models of peritonitis that are largely independent of classical melanocortin receptors, likely acting via IL-1β–related pathways, while the core HFRW region remains receptor-a…
DOI: 10.1124/jpet.103.051623 -
Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin
This study investigates the transdermal delivery of the KPV peptide using various enhancement strategies, including iontophoresis and microneedles, demonstrating significant increases in permeation rates compared to passive diffusion.
DOI: 10.1016/j.xphs.2017.03.017